A groundbreaking scientific investigation has illuminated a compelling link between persistent inflammation within the colon and the physical alteration of its tissues, thereby fostering an environment conducive to the development of colorectal cancer (CRC) in younger demographics. The study’s authors observed that prolonged inflammatory processes can induce a significant increase in the biomechanical stiffness of colon tissue, a condition that may facilitate the initiation, progression, and dissemination of cancerous cells. These seminal findings, detailed in the esteemed journal Advanced Science, usher in a new era of potential strategies for identifying individuals predisposed to this aggressive form of CRC and for formulating more precise therapeutic interventions.
This research represents a pivotal stride towards pinpointing individuals at elevated risk for early-onset CRC and uncovering novel avenues for their treatment, according to Dr. Emina Huang, M.D., M.B.A., a distinguished Professor of Surgery within the Division of Colon and Rectal Surgery and the Executive Vice Chair of Research for Surgery at UT Southwestern, who also holds professorships in Biomedical Engineering and is affiliated with the Harold C. Simmons Comprehensive Cancer Center. The collaborative effort was spearheaded by researchers at UT Southwestern Medical Center, in conjunction with scientific colleagues from The University of Texas at Dallas.
"This work marks the inaugural study to underscore the critical influence of biomechanical forces in the pathogenesis of early-onset CRC," stated Jacopo Ferruzzi, Ph.D., an Assistant Professor of Bioengineering at UT Dallas and Biomedical Engineering at UT Southwestern. "Our observations demonstrate consistency across various scales of analysis and establish a connection between the stiffening of connective tissue and alterations in the biochemical signaling pathways within cancer cells."
The observed phenomenon occurs against a backdrop of a significant and concerning demographic shift in cancer incidence. Traditionally, colorectal cancers that are not attributable to inherited genetic predispositions and typically manifest after the age of 50 are categorized as average-onset or sporadic CRCs. Over the past three decades, there has been a marked and sustained decline in both the diagnostic rates and mortality associated with these forms of cancer. Conversely, colorectal cancers diagnosed in individuals under the age of 50, designated as early-onset CRCs, have experienced a precipitous and alarming increase during the identical time frame. As of 2020, early-onset CRC constitutes approximately 12% of all diagnosed colorectal cancer cases within the United States, a figure that underscores the urgency of understanding its underlying mechanisms.
Despite this rapid upward trajectory, the fundamental etiology of early-onset CRC has remained largely elusive. Prior research efforts predominantly concentrated on extrinsic factors such as lifestyle choices, the prevalence of obesity, and environmental exposures that are known to precipitate chronic intestinal inflammation. However, the precise biological nexus between sustained inflammation and the burgeoning incidence of early-onset CRC has been inadequately elucidated.
The research team sought to unravel how chronic inflammation might instigate structural modifications within the colon. Dr. Huang posited that persistent inflammation can initiate a fibrotic process, characterized by scarring, which gradually remodels the architectural integrity of the tissue, leading to an escalation of its stiffness over time. Analogous tissue stiffening mechanisms have been implicated in the development of cancers in other organs, including the breast and pancreas. Consequently, her team embarked on an investigation to ascertain whether this same physiological pathway could be operative in the context of early-onset CRC.
To rigorously examine this hypothesis, the researchers meticulously analyzed colon tissue samples obtained from patients who had undergone surgical tumor resection at William P. Clements University Hospital and Parkland Health. The cohort comprised 19 tissue samples from individuals diagnosed with average-onset CRC and 14 samples from patients presenting with early-onset CRC. Crucially, each collected sample encompassed both the cancerous tissue itself and adjacent non-cancerous tissue, providing a comparative framework for analysis.
Subsequent biomechanical testing revealed a striking disparity: the colon tissue derived from patients with early-onset CRC exhibited significantly greater stiffness compared to that of older patients. This elevated rigidity was not confined to the tumorous regions alone but was also evident in the surrounding healthy tissues. This pervasive pattern strongly suggests that the process of tissue stiffening may precede the full manifestation of cancer, potentially acting as an early harbinger.
Further investigation into the molecular underpinnings of this increased rigidity pointed towards alterations in collagen, a key structural protein integral to connective tissues. Collagen undergoes significant remodeling, becoming more abundant and structurally modified during scarring processes. The colon tissue samples from early-onset CRC patients displayed collagen that was demonstrably denser, elongated, more mature, and exhibited a more uniform alignment when contrasted with samples from average-onset cases. These distinctive morphological features serve as robust indicators of extensive scarring within the colonic tissue of younger CRC patients.
An analysis of gene expression patterns corroborated these observations, revealing a heightened activity of genes associated with collagen metabolism, the formation of new blood vessels (angiogenesis), and inflammatory pathways in the early-onset CRC samples. These molecular signatures provide compelling evidence that chronic inflammation acts as a primary driver of the observed tissue stiffening.
The researchers also detected an amplified activation within a signaling pathway known as mechanotransduction, the fundamental biological process by which cells perceive and respond to physical forces within their microenvironment. This finding suggests that cancer cells in early-onset CRC may adapt their behavior, including proliferation and migratory capabilities, in direct response to the stiffness of their surrounding matrix.
Laboratory experiments provided further empirical support for this hypothesis. When colorectal cancer cells were cultured on substrates engineered to mimic increased tissue stiffness, they exhibited accelerated proliferation rates and a further enhancement of their own rigidity. Moreover, three-dimensional organoid models, meticulously constructed from CRC cells, demonstrated augmented growth in size and speed when cultivated in stiffer environments.
Collectively, these findings strongly indicate that a rigid colonic microenvironment may play a crucial role in both initiating and accelerating the development of colorectal cancer in younger individuals, as articulated by Dr. Huang. The research also suggests that therapeutic strategies targeting the mechanotransduction pathways could represent a promising avenue for impeding or halting cancer progression, an approach that is already under active investigation for other forms of cancer. Dr. Huang further elaborated that the development of diagnostic tools capable of quantifying intestinal stiffness could, in the future, serve as a valuable adjunct in identifying individuals at heightened risk for early-onset CRC, analogous to the established role of colonoscopies in screening for average-onset disease.
Dr. Huang holds the esteemed Doyle L. Sharp, M.D. Distinguished Chair in Surgical Research and is an integral member of the Cellular Networks in Cancer Research Program at the Simmons Cancer Center. The extensive research endeavors underpinning this study were generously supported by funding from the National Institutes of Health (grants R01 CA234307 and U01 CA214300), The University of Texas at Dallas Office of Research and Innovation through its CoBRA program, the Burroughs-Wellcome Trust, the American Society of Colon and Rectal Surgeons Resident Research Initiation Grant, The University of Texas at Dallas Bioengineering Research Award, the UT Southwestern Whole Brain Microscopy Facility, an Axioscan 7 Award, the Catherine and James McCormick Charitable Foundation which specifically supports research into early-onset colorectal cancer, and a National Cancer Institute (NCI) Cancer Center Support Grant (P30 CA142543).
About the Author
